Active Implantable Medical Devices Market Size 2031
The Active Implantable Medical Devices Market is expected to register a CAGR of 8.89% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Product [Implantable Cardioverter Defibrillators (Transvenous Implantable Cardioverter Defibrillators and Subcutaneous Implantable Cardioverter Defibrillators), Implantable Cardiac Pacemakers, Neurostimulators, Implantable Hearing Devices, Ventricular Assist Devices, and Implantable Heart Monitors/ Insertable Loop Recorders], and End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Active Implantable Medical Devices Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Active Implantable Medical Devices Market Segmentation
By Product [Implantable Cardioverter Defibrillators- Transvenous Implantable Cardioverter Defibrillators and Subcutaneous Implantable Cardioverter Defibrillators
- Implantable Cardiac Pacemakers
- Neurostimulators
- Implantable Hearing Devices
- Ventricular Assist Devices
- Implantable Heart Monitors/ Insertable Loop Recorders]
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Strategic Insights
Active Implantable Medical Devices Market Growth Drivers- Growing demand for minimally invasive procedures : Active implantable devices such as pacemakers, implantable cardioverter-defibrillators (ICDs), and neurostimulators are designed to provide minimally invasive treatment options for patients.
- Increasing prevalence of chronic diseases : The rising incidence of chronic diseases such as diabetes, hypertension, and neurological disorders is driving the demand for active implantable devices.
- Growing awareness of device-based treatments : Healthcare providers and patients are increasingly recognizing the benefits of device-based treatments, which are often more effective and cost-effective than traditional pharmaceutical therapies.
- Wireless connectivity : The trend towards wireless connectivity is enabling remote monitoring and control of active implantable devices, improving patient outcomes and reducing healthcare costs.
- Miniaturization : The development of smaller, more compact devices is enabling implantation at multiple sites, improving patient comfort and reducing surgical risks.
- Biodegradable materials : The use of biodegradable materials is reducing the risk of device-related complications and enabling the development of more complex implants.
- New indications : The discovery of new therapeutic indications for active implantable devices is expected to drive growth in the market
- Advancements in biomaterials : The development of new biomaterials with improved biocompatibility, durability, and functionality is expected to enable the creation of more sophisticated active implantable devices.
- Integration with artificial intelligence : The integration of artificial intelligence (AI) with active implantable devices is expected to improve diagnostic accuracy, treatment outcomes, and patient engagement.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Active Implantable Medical Devices Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Active Implantable Medical Devices Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The active implantable medical devices market is estimated to grow with a CAGR of 8.8% from 2023 to 2031.
Asia Pacific region is likely to witness fastest growth rate during the forecast period.
The active implantable medical devices market majorly consists of the players such as Medtronic, ABBOTT, Cochlear Ltd, Boston Scientific Corporation among others.
Biodegradable materials is likely to remain the key trend during the forecast period
The market drivers include increasing prevalence of dental diseases and advancements in dental technologies are driving the active implantable medical devices market
North America dominated the active implantable medical devices market in 2023
TABLE OF CONTENTS
1. INTRODUCTION 19
1.1 SCOPE OF THE STUDY 19
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 19
2. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET – KEY TAKEAWAYS 20
3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET – MARKET LANDSCAPE 23
3.1 OVERVIEW 23
3.2 MARKET SEGMENTATION 23
3.2.1 Global Active Implantable Medical Devices Market – By Product 24
3.2.2 Global Active Implantable Medical Devices Market – By End User 24
3.2.3 Global Active Implantable Medical Devices Market – By Geography 25
3.3 PEST ANALYSIS 26
3.3.1 North America – PEST Analysis 26
3.3.2 Europe – PEST Analysis 28
3.3.3 Middle East and Africa – PEST Analysis 32
3.3.4 South and Central America – PEST Analysis 34
4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET – KEY MARKET DYNAMICS 36
4.1 KEY MARKET DRIVERS 36
4.1.1 Increasing Burden of Cardiovascular Diseases, Neurological Disorders and hearing disorders 36
4.1.2 Technological Advancements and New Product Launches 36
4.1.3 Large pool of geriatric population 36
4.2 KEY MARKET RESTRAINTS 37
4.2.1 High Cost of Products and Procedures 37
4.2.2 High Rate of Product Recalls 37
4.3 KEY MARKET OPPORTUNITIES 38
4.3.1 Growing Healthcare Market In The Developing Economies 38
4.4 FUTURE TRENDS 38
4.4.1 Growing product innovations 38
4.5 IMPACT ANALYSIS 39
5. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET –GLOBAL ANALYSIS 40
5.1 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE FORECASTS AND ANALYSIS 40
5.2 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 41
5.3 EXPERT OPINIONS 41
6. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET ANALYSIS– BY PRODUCT 43
6.1 OVERVIEW 43
6.2 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES, BY PRODUCT 2017 & 2025 (%) 43
6.3 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET 44
6.3.1 Overview 44
6.3.2 Global Implantable Cardioverter Defibrillators Market Revenue And Forecasts To 2025 (US$ Mn) 44
6.3.3 Transvenous Implantable Cardioverter Defibrillators 45
6.3.3.1 Overview 45
6.3.3.2 Global Transvenous Implantable Cardioverter Defibrillators Market Revenue And Forecasts To 2025 (US$ Mn) 45
6.3.4 Subcutaneous Implantable Cardioverter Defibrillators 46
6.3.4.1 Overview 46
6.3.4.2 Global Subcutaneous Implantable Cardioverter Defibrillators Market Revenue And Forecasts To 2025 (US$ Mn) 46
6.4 IMPLANTABLE CARDIAC PACEMAKERS MARKET 47
6.4.1 Overview 47
6.4.2 Global Implantable Cardiac Pacemakers Market Revenue and Forecasts To 2025 (US$ Mn) 47
6.5 VENTRICULAR ASSIST DEVICES MARKET 48
6.5.1 Overview 48
6.5.2 Global Ventricular Assist Device Market Revenue And Forecasts To 2025 (US$ Mn) 48
6.6 IMPLANTABLE HEART MONITORS/INSERTABLE LOOP RECORDERS MARKET 49
6.6.1 Overview 49
6.6.2 Global Implantable Heart Monitors/Insertable Loop Recorders Market Revenue And Forecasts To 2025 (US$ Mn) 49
6.7 NEUROSTIMULATORS MARKET 50
6.7.1 Overview 50
6.7.2 Global Neurostimulators Market Revenue And Forecasts To 2025 (US$ Mn) 50
6.8 IMPLANTABLE HEARING DEVICES MARKET 51
6.8.1 Overview 51
6.8.2 Global Implantable Hearing Devices Market Revenue And Forecasts To 2025 (US$ Mn) 51
7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET ANALYSIS– BY END-USER 52
7.1 OVERVIEW 52
7.2 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES, BY END-USER 2017 & 2025 (%) 52
7.3 HOSPITALS MARKET 53
7.3.1 Overview 53
7.3.2 Global Hospitals Market Revenue And Forecasts To 2025 (US$ Mn) 53
7.4 AMBULATORY SURGERY CENTER MARKET 54
7.4.1 Overview 54
7.4.2 Global Ambulatory Surgery Center Market Revenue and Forecasts To 2025 (US$ Mn) 54
7.5 SPECIALTY CLINICS MARKET 55
7.5.1 Overview 55
7.5.2 Global Specialty Clinics Market Revenue And Forecasts To 2025 (US$ Mn) 55
8. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 56
8.1 OVERVIEW 56
8.2 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
8.3 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 57
8.3.1 North America Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 58
8.4 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 58
8.5 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 59
8.6 US ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
8.6.1 US Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 61
8.7 CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
8.7.1 Canada Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 63
8.8 MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
8.8.1 Mexico Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 65
9. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 66
9.1 OVERVIEW 66
9.2 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
9.3 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 68
9.3.1 Europe Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 68
9.4 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 69
9.5 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 69
9.6 GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
9.6.1 Germany Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 71
9.6.2 Germany Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 71
9.6.3 Germany Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 72
9.6.4 Germany Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By End User (US$ Mn) 72
9.7 UK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
9.7.1 UK Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 73
9.7.2 UK Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 74
9.7.3 UK Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 74
9.7.4 UK Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By End User (US$ Mn) 74
9.8 FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
9.8.1 France Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 76
9.8.2 FRANCE Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 76
9.8.3 France Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 77
9.8.4 France Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By End User (US$ Mn) 77
10. ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 78
10.1 OVERVIEW 78
10.2 ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
10.3 ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 79
10.3.1 Asia Pacific Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 80
10.4 ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 81
10.5 ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 81
10.6 JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82
10.6.1 Japan Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 82
10.6.2 Japan Active implantable medical devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 82
10.6.3 Japan Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 83
10.6.4 Japan Active implantable medical devices Market Revenue And Forecasts to 2025, By End user (US$ Mn) 83
10.7 CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
10.7.1 China Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 85
10.7.2 China Active implantable medical devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 86
10.7.3 China Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 86
10.7.4 China Active implantable medical devices Market Revenue And Forecasts to 2025, By End user (US$ Mn) 87
10.8 INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
10.8.1 India Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 88
10.8.2 India Active implantable medical devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 89
10.8.3 India Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 89
10.8.4 India Active implantable medical devices Market Revenue And Forecasts to 2025, By End user (US$ Mn) 90
11. MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 91
11.1 OVERVIEW 91
11.2 MIDDLE EAST AND AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
11.3 MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 92
11.3.1 Middle East & Africa Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 92
11.4 MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 93
11.5 MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 93
11.6 SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 93
11.6.1 Saudi Arabia Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 94
11.6.2 Saudi Arabia Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 95
11.7 U.A.E. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
11.7.1 U.A.E. Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 96
11.7.2 UAE Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 96
11.7.3 UAE Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 97
11.7.4 UAE Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By End User (US$ Mn) 97
11.8 SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 98
11.8.1 South Africa Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 98
11.8.2 South Africa Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 98
11.8.3 South Africa Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 99
12. SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 100
12.1 OVERVIEW 100
12.2 SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
12.3 SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 101
12.3.1 South and Central America Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 102
12.4 SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY ENDUSER US$ MN) 102
12.5 SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY COUNTRY (2017 & 2025) (%) 102
12.6 BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 104
12.6.1 Brazil Active implantable medical devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 104
12.6.2 Brazil Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 105
12.6.3 Brazil Active implantable medical devices Market Revenue And Forecasts to 2025, By End user (US$ Mn) 106
13. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET –KEY COMPANY PROFILES 107
13.1 ABBOTT 107
13.1.1 Key Facts 107
13.1.2 Business Description 107
13.1.3 Financial Information 108
13.1.4 Product Portfolio 108
13.1.5 SWOT Analysis 109
13.1.6 Key Developments 110
13.2 MEDTRONIC 111
13.2.1 Key Facts 111
13.2.2 Business Description 111
13.2.3 Financial Information 112
13.2.4 Product Portfolio 112
13.2.5 SWOT Analysis 112
13.2.6 Key Developments 113
13.3 COCHLEAR LTD. 115
13.3.1 Key Facts 115
13.3.2 Business Description 115
13.3.3 Financial Information 116
13.3.4 Product Portfolio 116
13.3.5 SWOT Analysis 116
13.3.6 Key Developments 117
13.4 BOSTON SCIENTIFIC CORPORATION 119
13.4.1 Key Facts 119
13.4.2 Business Description 119
13.4.3 Financial Overview 119
13.4.4 Product Portfolio 120
13.4.5 Swot Analysis 120
13.4.6 Key Developments 121
13.5 BIOTRONIK SE&CO. KG 122
13.5.1 Key Facts 122
13.5.2 Business Description 122
13.5.3 Financial Overview 122
13.5.4 Product Portfolio 122
13.5.5 Swot Analysis 124
13.5.6 Key Developments 124
13.6 LIVANOVA PLC 126
13.6.1 Key Facts 126
13.6.2 Business Description 126
13.6.3 Financial Overview 127
13.6.4 Product Portfolio 127
13.6.5 Swot Analysis 127
13.6.6 Key Developments 127
13.7 MED-EL 128
13.7.1 Key Facts 128
13.7.2 Business Description 128
13.7.3 Financial Overview 129
13.7.4 Product Portfolio 129
13.7.5 Swot Analysis 129
13.7.6 Key Developments 130
13.8 SONOVA 131
13.8.1 Key Facts 131
13.8.2 Business Description 131
13.8.3 Financial Overview 132
13.8.4 Product Portfolio 132
13.8.5 SWOT Analysis 133
13.8.6 Key Developments 134
13.9 WILLIAM DEMANT HOLDING A/S 135
13.9.1 Key Facts 135
13.9.2 Business Description 135
Financial Overview 136
13.9.3 Product Portfolio 136
13.9.4 SWOT Analysis 137
13.9.5 Key Developments 138
13.10 NUROTRON BIOTECHNOLOGY CO. LTD. 139
13.10.1 Key Facts 139
13.10.2 Business Description 139
13.10.3 Financial Information 140
13.10.4 Product Portfolio 140
13.10.5 SWOT Analysis 140
13.10.6 Key Developments 141
14. APPENDIX 142
14.1 ABOUT THE INSIGHT PARTNERS 142
14.2 GLOSSARY OF TERMS 143
14.3 METHODOLOGY 144
14.3.1 Coverage 145
14.3.2 Secondary Research 146
14.3.3 Primary Research 146
LIST OF TABLES
TABLE 1. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 57
TABLE 2. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 58
NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 58
TABLE 3. US ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 60
TABLE 4. US IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 61
TABLE 5. US ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 61
TABLE 6. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 62
TABLE 7. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 63
TABLE 8. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 63
TABLE 9. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 64
TABLE 10. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 65
TABLE 11. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 65
EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 68
TABLE 12. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 68
TABLE 13. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 69
GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 71
TABLE 14. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 72
TABLE 15. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 72
TABLE 16. UK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 74
TABLE 17. UK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 74
TABLE 18. UK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 74
FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 76
TABLE 19. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 77
TABLE 20. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 77
ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 79
TABLE 21. ASIA PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 80
ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 81
JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 83
TABLE 22. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 83
JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 83
CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 86
TABLE 23. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 86
CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 87
INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 89
TABLE 24. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 90
INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 90
MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 92
TABLE 25. MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 92
TABLE 26. MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 93
TABLE 27. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 94
TABLE 28. SAUDI ARABIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 95
TABLE 29. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 95
TABLE 30. U.A.E. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 97
TABLE 31. UAE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 97
TABLE 32. U.A.E. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97
TABLE 33. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 98
TABLE 34. SOUTH AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 99
TABLE 35. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 99
TABLE 36. SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 101
TABLE 37. SOUTH AND CENTRAL AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 102
SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY ENDUSER 102
TABLE 38. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 105
TABLE 39. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 105
TABLE 40. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 106
TABLE 41. GLOSSARY OF TERMS, ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET 143
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2017 & 2025 20
FIGURE 2. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT, MARKET SHARE (%), 2017 21
FIGURE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET BY END USER, MARKET SHARE (%), 2017 21
FIGURE 4. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION 23
FIGURE 5. ACTIVE IMPLANTABLE MEDICAL DEVICES SEGMENTATION, BY REGION 24
FIGURE 6. NORTH AMERICA PEST ANALYSIS 26
FIGURE 7. EUROPE PEST ANALYSIS 28
FIGURE 8. ASIA PACIFIC PEST ANALYSIS 30
FIGURE 9. MIDDLE EAST AND AFRICA PEST ANALYSIS 32
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 34
FIGURE 11. ACTIVE IMPLANTABLE MEDICAL DEVICES IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 39
FIGURE 12. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET – REVENUE FORECASTS AND ANALYSIS – 2017- 2025 40
FIGURE 13. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 41
FIGURE 14. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT 2017 & 2025 (%) 43
FIGURE 15. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
FIGURE 16. GLOBAL TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 17. GLOBAL SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
FIGURE 18. GLOBAL IMPLANTABLE CARDIAC PACEMAKERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 19. GLOBAL VENTRICULAR ASSIST DEVICE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
FIGURE 20. GLOBAL IMPLANTABLE HEART MONITORS/INSERTABLE LOOP RECORDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
FIGURE 21. GLOBAL NEUROSTIMULATORS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 22. GLOBAL IMPLANTABLE HEARING DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 23. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY END-USER 2017 & 2025 (%) 52
FIGURE 24. GLOBAL HOSPITALS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
FIGURE 25. GLOBAL AMBULATORY SURGERY CENTER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 26. GLOBAL SPECIALTY CLINICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
FIGURE 27. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OVERVIEW, BY COUNTRY (2017) 56
FIGURE 28. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
FIGURE 29. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 59
FIGURE 30. US ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
FIGURE 31. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
FIGURE 32. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
FIGURE 33. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OVERVIEW, BY COUNTRY (2017) 66
FIGURE 34. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
FIGURE 35. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY (2017 & 2025) 69
FIGURE 36. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
FIGURE 37. UK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
FIGURE 38. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
FIGURE 39. ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OVERVIEW, BY COUNTRY (2017) 78
FIGURE 40. ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
FIGURE 41. ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 81
FIGURE 42. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82
FIGURE 43. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
FIGURE 44. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
FIGURE 1. MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OVERVIEW, BY COUNTRY (2017) 91
FIGURE 2. MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
FIGURE 3. MIDDLE EAST AND AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 93
FIGURE 4. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 94
FIGURE 5. U.A.E. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
FIGURE 6. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 98
FIGURE 7. SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OVERVIEW, BY COUNTRY (2017) 100
FIGURE 8. SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
FIGURE 9. SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY COUNTRY (2017 & 2025) (%) 102
FIGURE 10. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 104
The List of Companies - Active Implantable Medical Devices Market
- Medtronic
- ABBOTT
- Cochlear Ltd.
- Boston Scientific Corporation
- BIOTRONIK
- MED-EL
- SONOVA
- William Demant Holding A/S
- LivaNova PLC
- Nurotron Biotechnology Co. Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For